Literature DB >> 30099

Effect of alcohol and benzodiazepines on performance as related to personality characteristics. Personality characteristics among healthy "placebo reactors" and nonreactors.

M Linnoila, R Liljequist, J Olkoniemi, I Saario.   

Abstract

For 2 weeks 40 volunteers received either 5 mg diazepam, t.i.d., or 10 mg chlordiazepoxide, t.i.d., and placebo. A choice reaction test, two coordination tests, and an attention test were administered to the subjects on the 14th day of each treatment. Thirty minutes before the tests, the subjects ingested either alcohol., 5g/kg or a placebo drink, incombination with the last capsule. After the test the subjects rated the quality of their treatment as placebo, tranquilizer, or stimulant. The psychological tests taken before the treatments were Eysenck's EPIC-NESI, Taylor's Manifest Anxiety Scale (MAS), and Cattell's 16 PF inventory. A multiple regression analysis was computed. Personality factor scores found to be associated with a strong effect of the benzodiazepines were 16 PF's A, C, L, N, and Q, and EPIC's E. The effect of alcohol was associated with a high score of 16 PFs B factor. Personality factors associated with "placebo reactors" and nonreactors were investigated, as well. Those subjects on placebo indicating their treatment to be active were classified as "placebo reactors". A discriminant analysis revealed that 16PF's O and I factors discriminated effectively "placebo reactors" from nonreactors, and EPIC's SE and 16 PF's L factor nonreactors from "reactors".

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 30099     DOI: 10.1055/s-0028-1094545

Source DB:  PubMed          Journal:  Pharmakopsychiatr Neuropsychopharmakol        ISSN: 0031-7098


  2 in total

1.  The healthy volunteer in clinical pharmacology: personality and motivation.

Authors:  F P Meyer; R Haschke; F W Röhl
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

2.  The effect of level of depression on the use of visual analogue scales by normal volunteers.

Authors:  M Peet; S Ellis; R A Yates
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.